HSV-tk + Valacyclovir + SBRT + Chemotherapy for Recurrent GBM — Stella

stellabeta Find trials matched to me Trial Match

Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

HSV-tk + Valacyclovir + SBRT + Chemotherapy for Recurrent GBM — Stella

Recruiting

Back to Glioblastoma Multiforme trials

Phase 1 — Testing in a small group (usually 20–80 people) to find a safe dose and watch for side effects.

Trial locations(1 site)

United States

Houston Methodist Neurological Institute, Houston, Texas

Key details

Phase

Safety & dosing

Sponsor

David Baskin MD

Collaborators

Center for Cell and Gene Therapy, Baylor College of Medicine, The Methodist Hospital Research Institute

Enrollment target

~62 participants

Started

December 2017

Primary completion

December 2026

Age range

18 Years and older

Last updated March 2026

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

Follow this trial

Get notified in plain English when this trial's status changes. No account required.

View full record on ClinicalTrials.gov